DETERMINING DISEASE CAUSALITY FROM EXPERIMENTAL TOXICOLOGY STUDIES
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Preston R
. Extrapolations are the Achilles heel of risk assessment. Mutat Res. 2005; 589(3):153-7.
DOI: 10.1016/j.mrrev.2005.03.001.
View
2.
Haseman J
. Statistical support of the proposed National Toxicology Program protocol. Toxicol Pathol. 1983; 11(1):77-82.
DOI: 10.1177/019262338301100113.
View
3.
Dumitrescu R, Cotarla I
. Understanding breast cancer risk -- where do we stand in 2005?. J Cell Mol Med. 2005; 9(1):208-21.
PMC: 6741339.
DOI: 10.1111/j.1582-4934.2005.tb00350.x.
View
4.
Eustis S, Hailey J, Boorman G, Haseman J
. The utility of multiple-section sampling in the histopathological evaluation of the kidney for carcinogenicity studies. Toxicol Pathol. 1994; 22(5):457-72.
DOI: 10.1177/019262339402200501.
View
5.
Tomatis L
. Role of experimental and epidemiological evidence of carcinogenicity in the primary prevention of cancer. Ann Ist Super Sanita. 2006; 42(2):113-7.
View